Abstract
OBJECTIVE—To study the epidemiology of pyridoxine dependent seizures and other forms of pyridoxine responsive seizures. DESIGN—Monthly notifications to the British Paediatric Surveillance Unit over two years. Questionnaire follow up. SETTING—UK and the Republic of Ireland. PATIENTS—Children aged 15 years or younger whose seizures respond to pyridoxine. INTERVENTIONS—None. MAIN OUTCOME MEASURES—Numbers of children with definite, probable, and possible pyridoxine dependent seizures or other seizures responsive to pyridoxine. RESULTS—Point prevalence and birth incidence: 1/687 000 and 1/783 000, respectively (definite and probable cases); 1/317 000 and 1/157 000, respectively (all types of pyridoxine responsiveness). NOTIFICATIONS—Pyridoxine dependency: 14 definite, 9 probable, and 10 possible cases; neonatal seizures not meeting case definitions: 7; infantile spasms: 5. Eight of 18 families of definite/probable cases had 2 affected siblings. Just over a third had atypical presentations and just under a third had features and/or initial diagnoses of birth asphyxia and neonatal hypoxic ischaemic encephalopathy. CONCLUSIONS—Pyridoxine dependency is rare. Atypical presentations are relatively frequent. A trial of pyridoxine is justified in all cases of early onset intractable seizures or status epilepticus, whatever the suspected cause.
Full Text
The Full Text of this article is available as a PDF (71.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bankier A., Turner M., Hopkins I. J. Pyridoxine dependent seizures--a wider clinical spectrum. Arch Dis Child. 1983 Jun;58(6):415–418. doi: 10.1136/adc.58.6.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bass N. E., Wyllie E., Cohen B., Joseph S. A. Pyridoxine-dependent epilepsy: the need for repeated pyridoxine trials and the risk of severe electrocerebral suppression with intravenous pyridoxine infusion. J Child Neurol. 1996 Sep;11(5):422–424. doi: 10.1177/088307389601100519. [DOI] [PubMed] [Google Scholar]
- Baxter P., Griffiths P., Kelly T., Gardner-Medwin D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol. 1996 Nov;38(11):998–1006. doi: 10.1111/j.1469-8749.1996.tb15060.x. [DOI] [PubMed] [Google Scholar]
- Ekelund H., Gamstorp I., Von Studnitz W. Apparent response of impaired mental development, minor motor epilepsy and ataxia to pyridoxine. Acta Paediatr Scand. 1969 Nov;58(6):572–576. doi: 10.1111/j.1651-2227.1969.tb04764.x. [DOI] [PubMed] [Google Scholar]
- Goutières F., Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol. 1985 Feb;17(2):117–120. doi: 10.1002/ana.410170203. [DOI] [PubMed] [Google Scholar]
- Guilarte T. R. Vitamin B6 and cognitive development: recent research findings from human and animal studies. Nutr Rev. 1993 Jul;51(7):193–198. doi: 10.1111/j.1753-4887.1993.tb03102.x. [DOI] [PubMed] [Google Scholar]
- Haenggeli C. A., Girardin E., Paunier L. Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr. 1991 May;150(7):452–455. doi: 10.1007/BF01958419. [DOI] [PubMed] [Google Scholar]
- Ohtahara S., Ohtsuka Y., Yamatogi Y., Oka E., Yoshinaga H., Sato M. Prenatal etiologies of West syndrome. Epilepsia. 1993 Jul-Aug;34(4):716–722. doi: 10.1111/j.1528-1157.1993.tb00451.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.